Update on COVID-19

Our Commitment during the Coronavirus Pandemic


Corona Ticker

We are contributing to the global fight against the coronavirus through our products and expertise in health and nutrition. Our corona ticker provides an up-to-date overview of our activities.

May 28

03:00 p.m. CEST: Can Food Supply Chains Cope with COVID-19?
From farmers and field workers, to food processors and retailers, the global pandemic is causing problems at every stage of the supply chain.
To understand the challenges the world faces, we spoke to leading experts on global food supply chains to ask: how are we preventing a health crisis from becoming a food crisis?
Read the full story in the Bayer Magazine.

09:00 a.m. CEST: Six Months That Will Change Global Food Security, One Way or the Other
COVID-19 has rocked economies and disrupted daily lives all over the world. Whether the global food system, especially in developing countries, emerges stronger or more fragile will depend on what happens next. For smallholder farmers in developing countries, the “end” of the coronavirus pandemic might be better described as the beginning of a new reality for agriculture.

May 27

05:00 p.m. CEST: “Good Bugs vs. Bad Bugs” is the latest theme in Science at Home with Bayer
Did you know there are 30 million species of insects? Not all of them are pests, however: there are neutral/beneficial and destructive insects. The latest edition of Science at Home with Bayer shares all sorts of bug themed activities and recipes to learn what makes a bug a bug, how we determine if it’s a good or bad bug, and what we can do to protect ourselves from destructive insects while being sure not to hurt the beneficial ones. And 11-year-old Kellen Hayes is back to interview entomologist Dr. Krishna Bayyareddy whose love for bugs began as a young child growing up on?a farm?in India. Find out about Krishna’s childhood, work as an entomologist, and meet his six-year-old daughter, Krithi, who teams up with her dad to share some fun and interesting bug facts!

03:00 p.m. CEST: COVID-19 demonstrates the increasing importance of digitalization
“Farmers, like everyone else, have had their normal business routines completely disrupted, and digital technologies have proven to be a life-line during this crisis.”
You can read the interview John Raines, CCO of The Climate Corporation gave EURACTIV on their website.

May 21

09 a.m. CEST: Bayer Foundation supports leading social entrepreneurs in their fight against COVID-19 in Africa
To date, the WHO has registered over 86,000 COVID-19 cases in Africa. Most countries are lacking solid health systems and intensive care units. Via the Bayer Foundation, we partner with leading Social Entrepreneurs and organizations to prevent and limit the potential spread of COVID-19 on the continent. Monika Lessl, who heads the Bayer Foundation and Societal Engagement at Bayer, highlights four examples of these important partnership in a post on LinkedIn.

May 20

03:00 p.m. CEST: Digital Technology is Powering Agriculture in a Time of Crisis
“Successful global organizations cannot wait until a crisis emerges to uncover problems and pursue solutions. Bayer’s relentless, established pursuit of digital transformation has allowed us to not only adapt, but advance our operations while accounting for the current, unfortunate norms.” Read the whole article by Ingo Elfering, CIO, Head of Digital Transformation and Member of the Crop Science Executive Leadership Team on LinkedIn.

May 19

03:00 p.m. CEST: Virtual World Medical Innovation Forum - Healthcare Leaders Reflect on COVID-19
11,000 registrants representing 95 countries, 47 states and 3200 organizations joined the World Medical Innovation Forum on May 11.
In reaction to the global pandemic, the annual meeting had been turned into a one-day digital broadcast special on COVID-19 and infectious diseases.
Joerg Moeller, Head of Research & Development of our Pharmaceuticals Division and Mike Devoy, Chief Medical Officer of Bayer AG and Head Medical Affairs & Pharmacovigilance represented Bayer.
You can now watch the recordings of their sessions on YouTube.

Joerg Moeller about “Creating, Collaborating, and Accelerating Discovery During and After a Pandemic”
Panel discussion with Mike Devoy about “The Role of AI and Big Data in Fighting COVID-19”

May 18

Colleagues from Algeria preparing necessary food basket to donate to families in need
‘Hemaya’ initiative in Egypt: Bayer provides educational and hygienic kits

04:00 CEST: Bayer Continues to Donate Money and Hygienic Kits to Support the Fight against COVID-19
In Algeria, Bayer donated €20,000 to support Algerian health authorities for the acquisition of SARS-COV2 tests. The donation was established through United Nation’s Development Program (UNDP) which is supporting on the supply of medical equipment for health staff in hospitals in the most affected areas. Furthermore, €80,000 were donated to the Moroccan special fund. The money will for example cover the costs of upgrading medical infrastructure and additional means to be acquired in the event of an emergency. Additionally, Bayer supported the Ministry of Health Program by providing medicines indicated in the official care protocol of the Ministry.
In Tunisia, a monetary donation of €20,000 was given to SEPHIRE. A dedicated Commission fund is created to collect donations under the supervision of the Tunisian Ministry of Health. The role of this commission is to cover actual needs regarding the health department and fight the social impacts of the pandemic.
In addition, Bayer in Middle East launched an extended partnership with “Sonaa Al-Khair” to support the “Hemaya” initiative in Egypt. Bayer’s role in the initiative includes providing hygienic kits of gloves, face masks and alcohol supplies. In addition, along with Sonaa El-Khair, Bayer raises awareness of means and measures of protection against COVID-19 and provides sanitizing services. The initiative is organized under the auspices of the Egyptian Prime Minister Dr. Mostafa Madbouly and under the supervision of Ministry of Social Solidarity.

May 12

11:00 a.m. CEST: Science is in the Air: check out the latest edition of STEM fun in “Science at Home with Bayer”
Science tells us that air is matter, which means it takes up space and has mass. But how can we know that air has mass if we can’t see it? In a new segment, “Learn with a Scientist”, Dr. Kimberly Hodge-Bell and her two “junior scientist” daughters demonstrate some simple experiments you can recreate at home to prove it. You’ll also find a variety of activities and recipes you and your kids can do to learn all about air, the atmosphere, weather phenomena, and more. And don’t miss the return of 11-year old Kellen to interview TV meteorologist and STEM educator personality, Jason “Mr. Science” Lindsey, who shares how he came to be a weatherman, his love of science, and through a cool demonstration, how to make a real cloud! Read more in our Bayer-Magazine.

09:00 a.m. CEST: Bayer Employees in the US Show Their Support for Customers and Communities
In response to COVID-19, employees form our Crop Science division in the field and working from home have been coming up with many creative ways to show support for their customers and communities. One of many examples is a virtual food drive with Operation Food Search, an organization that distributes food and necessities to 330 community partners in Missouri and Illinois, which raised almost USD 28,500. Our employees are also looking for ways to lend support to essential workers – such as healthcare providers, police officers, and others. Bayer’s Technical Discovery Center in Chesterfield manufactures plastic face shields for health care workers using a 3D printer.
Similary, in Iowa and Hawaii, teams have been printing personal protection equipment parts and ventilator components through the use of their 3D printers. Another team wanted to raise awareness on the importance of farmers and made rubber bracelets with printed messages that say “#stillfarming” and “I am Essential.” More than 4,000 bracelets have already been distributed to seed partners, growers and retailers in Indiana and Kentucky.

May 11

10:00 a.m. CEST: How to Take Care of Your Immune System
In these times many people are looking for guidance on how to protect themselves from getting the coronavirus. Apart from hygienic measures, maintaining or supporting a healthy immune system is also an essential part of staying healthy. What role does the immune system play when it comes to viral infections and what you can do to boost it? We have asked our experts Dr. Bernard Ng, Physician and Dr. Robert Eichler, Virologist. Read more in our Bayer Magazine.

May 8

Zoom image

10:00 a.m. CEST: Growing Enough Food during the Coronavirus Pandemic
Droughts, floods or infestations of pests – Overcoming unpredictable hurdles goes with the job for Farmers, but the pandemic is bringing a range of new challenges to growing the food people depend upon.
We spoke to farmers and industry figures around the world to learn how they are adapting in this unprecedented time. You can read the article in our Bayer Magazine.

08:00 a.m. CEST: Bayer donates more than €346,000 to mitigate the effects of the Coronavirus in Argentina
The donation will allow the incorporation of supplies, medical and security equipment in various hospitals and, in addition, funds will be allocated to the campaigns of the Argentine Red Cross and #Seamos Uno.

May 7

01:30 p.m. CEST: Launch of “Worldwide Empathy for Medics” Initiative
Healthcare professionals are facing unprecedented challenges at the forefront of the corona crisis. Experts point out the high risk for them of suffering from post-traumatic stress. A new international initiative "Worldwide Empathy for Medics" has just been launched to provide empathetic support and listening to healthcare professionals and all hospital workers and caregivers on the brink of coronavirus emergencies. Dr. Luc Peetermans from Belgium is behind this initiative, in collaboration with the Blabla Foundation, a training center specialized in communication and therapy as well as an international team of trainers in NonViolent Communication. As partner of healthcare professionals, Bayer supports this initiative and the medical profession in the fight against the coronavirus.

May 5

10:30 a.m. CEST: Bayer supports farmers in India with two initiatives
The Indian state of Maharashtra is famous for grape cultivation and its export quality grapes. Due to the restrictions caused by COVID-19, grape farmers are struggling to sell their produce. Bayer has stepped in to link grape farmers to offtakers such as DeHaat and AgriBazaar so that they can go on selling their products. To read more, find a Facebook post here.

Furthermore, Bayer India collaborates with India Post to enable smallholders to withdraw money. Due to the Covid-19 lockdown and related health & safety concerns, smallholders farmers in India are facing difficulties to withdraw cash from their Post Office savings accounts. Together with India Post, Bayer has set up a temporary kiosk with cash, biometric scanners and smartphones at one of its Better Life Farming Centers in Uttar Pradesh. More than 100 smallholders took the opportunity to carry out cash transactions and additionally received face masks and hand sanitizers from the Bayer team. To read more, find a Facebook post here.

May 4

04:00 p.m. CEST: Article by Liam Condon - A World Without Hunger?
”Everything becomes less important during a crisis, everything but our most fundamental needs: health and nutrition.” Read here the perspective of Liam Condon, President of our Crop Science division, about the challenges and learnings during the COVID-19 pandemic.

11:00 a.m. CEST: Bayer’s contribution in the fight against COVID-19
The Coronavirus has shown us vividly how crucial health and nutrition are. As a leading company in both areas, Bayer has an enormous responsibility to make a contribution during the crisis. With this video our CEO Werner Baumann thanked all our employees for their tremendous contribution in the fight against the pandemic. Read his LinkedIn post

April 29

Zoom image

09:00 a.m. CEST: “Science at Home” asks ‘Why Chemistry Matters?’
You may not have thought about it before, but chemical reactions are happening all around us. Learn about the basics of chemistry, the states of matter and common chemical reactions with a variety of fun experiments and recipes you can do with your kids at home. In this week’s “Meet a Scientist” interview, 11-year-old Kellen speaks with Dr. Alexander Hillisch, Head of Computational Molecular Design for Bayer Pharmaceuticals, who leads a team of researchers working to help people suffering from cardiovascular conditions such as heart disease and stroke. Learn more about chemistry, his exciting job, and how scientists like himself are thinking about ways they can help in the global fight against the coronavirus.

April 28

Zoom image

05:00 p.m. CEST: The first virtual stockholders' meeting
Today, history was made: Bayer held the first virtual stockholders' meeting by a DAX company. How we prepared the event in times of the COVID-19 pandemic can be seen here in a short video. The full recording of the AGM can be found here.

April 27

09:00 a.m. CEST: Good start to 2020 –
activities marked by COVID-19
Bayer has registered a good start to 2020, with business activities in the first quarter greatly marked by the COVID-19 pandemic. “With our life science product portfolio in the areas of health and nutrition, we have shown our ability to successfully continue our business operations in a challenging environment and deliver a positive contribution for our stakeholders even during a time of crisis,” says CEO Werner Baumann. Read more in the press release here.

April 24

01:00 p.m. CEST: Bayer to donate tablets of chloroquine for use in Italy
Based on a protocol signed with the AIFA (Italian Medicines Agency), Bayer will donate approximately one million chloroquine tablets for COVID-19 treatment in Italy.
AIFA’s Technical-Scientific Commission added chloroquine, along with other drugs, to the list of medicines for so-called off-label use outside of the established indications to treat patients with COVID-19 on March 13, 2020. Read more here.

Zoom image

11:00 a.m. CEST: Bayer thanks healthcare professionals by donating Bepanthen
Across the world, healthcare workers are working tirelessly to beat COVID19. Even as face masks, gloves and frequent hand washing are taking a toll on their skin, they keep going. We want to thank them for their dedication by donating Bepanthen to help care for their skin. The donations to over 100,000 healthcare professionals are being made via NGOs and government institutions in 25 countries. Read more in this LinkedIn post by Heiko Schipper, President Bayer Consumer Health. 

April 22

04:00 p.m. CEST: Bayer Mexico produces and donates sanitizers and face shields. In the fight against COVID-19, Proquina, the site for pharmaceutical agents in Mexico, produces alcohol-based hand sanitizers. So far, a quantity of 1,000 liters has been generated, another 10,000 liters are currently in preparation.
In addition, a converted 3D printer in Lerma, Mexico, is now producing transparent face shields. Bayer donates both to hospitals, health centers and other health facilities in the country.

08:00 a.m. CEST: Starting today, Bayer will be distributing cloth masks to its employees. Every employee will be receiving four cloth masks that can be used as an additional health measure in places where there is significant community-based transmission. This can help employees in following existing or possible country guidance on continue wearing masks in public. Around 400,000 cloth masks will be available for employees. Bayer also donated masks to external partners, you can find an overview of our activities here in our Bayer magazine.

April 21

02:00 p.m. CEST: Our Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19. It will support the program with a financial commitment of CAD 1.5 million (approximately EUR 1 million) and the supply of products. Two studies will evaluate the safety and efficacy of different combination therapies including Bayer’s chloroquine and interferon beta-1b. It is planned to include more than 60 contributing research locations involving 6.000 patients.

April 20

02:00 p.m. CEST: Chinese radiologists share experience of treating COVD-19 patients with global peers. As the Coronavirus is still rampaging through the world, a medical academic webinar dedicated to sharing Chinese radiologists’ diagnosis experience of COVID-19 cases with their counterparts in 15 countries of Latin America, a continent also severely affected by the pandemic, was held on April 17th, joined by over 400 participants.
It was the 3rd webinar of an online medical academic forum series which is organized by the Chinese Radiology Society and China International Medical Foundation, and exclusively sponsored by Bayer China Radiology. With the purpose of promoting global solidarity in combating COVID-19, the forum series has 8 webinars and aims to connect radiologists around the world including Italy, Germany, Latin America countries and Asia-Pacific countries.

Zoom image

10:00 a.m. CEST: Science at Home with Bayer celebrates Earth Day. April 22 marks the 50th anniversary of Earth Day and reminds us that we only have one planet, and we have to take good care of it! Have a look at Science at Home’s latest content package of activities you can do at home with your kid as so many of us continue to juggle distance learning during the coronavirus pandemic. In this week’s “Kid Talk: Meet a Scientist” segment, 11-year old Kellen continues his quest to ask scientists questions kids his age may want to know. Kellen speaks to Dr. John Purcell, Head of Vegetables Research and Development at Bayer, to find out what vegetable breeding has to do with protecting the planet and as a bonus, gets some tips for sustainably growing veggies of his own.

April 17

05:00 p.m. CEST: Bayer will donate nearly EUR 2 million to help fight the pandemic Covid-19 in France and Brazil.
1 million will be donated to the “All united against the virus” alliance set up by the Fondation de France, the Assistance Publique – H?pitaux de Paris (AP-HP) hospital network and the Pasteur Institute. The money will enable the alliance to provide psychological support for caregivers, patients and their families as well as to improve the patient care pathway. It will also be used to fund research projects to better understand the coronavirus and the ongoing pandemic, and to develop antibody detection tests, effective treatments and vaccines. Read more here.

Furthermore, Bayer announces the donation of roughly EUR 1 million to help fight the pandemic in Brazil. We believe that collaboration is the key to deal with this crisis, so Bayer will allocate funds for three different initiatives: the Arrecada??o Solidária, a Federal Government's project, the United Nations Children's Fund (UNICEF) and the purchase of safety items and hospital supplies. Read the whole news here.

Zoom image

01:30 p.m. CEST: Protective masks have been in short supply since the beginning of the coronavirus crisis. At Bayer, a task force is currently working around the clock to ensure that there is no shortage of protective equipment in production plants and laboratories. We are also donating to external partners wherever possible – for example, today’s donation of 200,000 protective masks to the German Red Cross. You can read more about our activities to combat the shortage of protective masks in our magazine story.

April 16

13:30 p.m. CEST: How can Bayer support the production of a possible vaccine against the coronavirus? "We will provide support in terms of the requisite additional production capacity if new vaccines are successfully tested and approved. We don't currently manufacture vaccines, but we would be able to do so within the next twelve months if it was needed", CEO Werner Baumann said in an interview in the Morning Briefing with Gabor Steingart. You can listen to it here (in German).

How can we organize an orderly exit, if the decision is taken to relax measures against the spread of Covid-19? Baumann talked about this in his guest article for FAZ, which you can now also find in our blog.

April 15

SpeakUpAfrica /PATH, Zero Malaria Starts with me campaign

05:00 p.m. CEST: To prevent Covid-19 from spreading in Senegal, the Bayer Foundation collaborated with its partners, the Senegal Ministry of Health and the health organization PATH. Together, they have redesigned the existing Bayer Foundation anti-malaria program to provide a quick Coronavirus response. In this LinkedIn article, PATH Country Director Aminatou Sar explains what that looks like.

05:00 p.m. CEST: To prevent Covid-19 from spreading in Senegal, the Bayer Foundation collaborated with its partners, the Senegal Ministry of Health and the health organization PATH. Together, they have redesigned the existing Bayer Foundation anti-malaria program to provide a quick Coronavirus response. In this LinkedIn article, PATH Country Director Aminatou Sar explains what that looks like.

11:00 a.m. CEST: Science at home with Bayer posted a new fun science education content package on "The Science of Growing Food" to engage kids of all ages at home as many of us continue to deal with distance learning models or school closures as a result of the global spread of COVID-19.

Zoom image

10:00 a.m. CEST: Covid-19 is restricting public and private life all over the world. In addition to many industries and all social classes, this also applies to the artists who cannot perform as all events have been cancelled. Bayer Arts & Culture and the Bayer sites in Berlin and Weimar would like to provide financial and mental support for some of these creative individuals as a sign of solidarity during this period, and have therefore initiated the "stART Festival Special". The festival features artists who have already enriched Bayer's cultural offerings in the past. All artists have made a video available to Bayer for this campaign with a length of 15 to a maximum of 45 minutes. You can watch the videos here.

April 14

12:00 p.m. CEST: Is Chloroquine, the active ingredient of the Bayer drug Resochin, a potential treatment for patients with Covid-19? Our Chief Medical Officer Michael Devoy and Matthias Berninger, Head of Public Affairs & Sustainability, talk about questions related to Resochin in a short video.

Zoom image

10:00 a.m. CEST: We’re donating 8 million tablets of chloroquine to the German government to support the fight against COVID-19. The tablets will be handed over to the responsible authorities in the next days. In the past weeks, Bayer already donated several million tablets of chloroquine to governments of several other countries, including countries heavily impacted by the pandemic like China, Italy and the US.

April 9

09:00 a.m. CEST: ”I am very proud of many colleagues at Bayer who came up with ideas how we can support”. Matthias Berninger, Head of Public Affairs & Sustainability at Bayer, in a Concordia webcast about our response to the COVID-19 crisis.

Watch the recording of the webcast here.

April 8

05:00 p.m. CEST: Bayer is supporting the fight against the corona pandemic in Spain with a comprehensive aid package. The company is donating €800,000 to the national health system in Spain for the purchase of urgently needed medical equipment and hospital beds.
Further contributions of more than €100.000 include the donation of test equipment for the diagnosis of Covid-19 to one of the research centers of Consejo Superior de Investigaciones Científicas (CSIC), a prestiogious public research institution, as well as support for the “Coronavirus Emergency in Spain" program of the Red Cross.

April 6

Zoom image

06:00 p.m. CEST: Bayer launches Science at Home, a weekly series to feature STEM educational resources parents can use to keep their kids learning while staying at home during the Corona crisis. Science doesn’t just happen in labs – science is all around us and powers everything we do! Many of us are adjusting to a new normal of juggling remote work with distance learning models or daycare and school closures due to the global spread of COVID-19. Our new initiative in Bayer Magazine offers some fun science education content parents can use at home. It will feature weekly themed packages of articles, videos, activities, and experiments you and your kids can do together.

April 4

08:00 a.m. CET: Early findings from laboratory testing and initial clinical trials indicate that Resochin, our over 80-year-old anti-malarial drug, reduces the viral load in COVID-19 patients. Today we handed over the first 600,000 tablets to the German Army (Bundeswehr) free of charge.

April 3

02:00 p.m. CEST: Matthias Berninger, Head of Public Affairs & Sustainability at Bayer, is the guest of a webinar hosted by Concordia. He will explore Bayer’s response to the COVID-19 crisis and how we continue to provide support during the pandemic. The webcast will take place on April 7, 7:00 p.m. (CEST). If you want to join the webcast, please click here. Concordia is a nonprofit, nonpartisan organization in the U.S. dedicated to actively fostering, elevating, and sustaining cross-sector partnerships for social impact.

Zoom image

11:45 a.m. CEST: The Bayer Italia team reached an incredible milestone recently by getting the first Crop Science field trials in the ground in Lombardy – one of the regions hit hardest by coronavirus. Though the world is different today than it was some weeks ago, the season is about to start. April is planting time to be able to harvest later in the year, and farmers can’t rest or wait to get their job done – and our employees around the globe are teaming up with our customers to ensure that agriculture continues. Together, we’ll overcome Covid-19!

09:00 a.m. CEST: Our CEO Werner Baumann gave an interview to Fortune on Resochin donations during COVID-19 crisis.
“The most important thing right now is that we do everything to make our contribution to help people survive in this monumental crisis”.
Watch the full interview on fortune.com.

April 2

04:00 p.m. CEST: How does success look like in times of working remotely due to Corona? Our colleague Megan McNamee, Climate?Customer Success Specialist, discusses how her team at Climate Corp is staying connected and helping customers to make data driven decisions.

April 1

Zoom image

09:00 a.m. CEST: Our newly established testing laboratory in Berlin which supports the fight against the Corona virus is already running: In the lab, our employees – more than 140 have volunteered – are able to conduct up to 1,000 additional SARS-CoV-2 tests per day. This helps to slow down the spread of the virus as fewer infections remain undetected and infection chains can be better reconstructed.

March 31

10:00 p.m. CEST: Employees all over the world can submit their ideas and challenges for the fight against Corona on our internal WeSolve collaboration platform. Together we can make an impact by leveraging our diverse resources - as experts, scientists, innovators or coaches, to keep working effectively and support each other in these difficult times. A first idea - how to help colleagues increase their resilience and mental wellbeing - has already been implemented.

03:00 p.m. CEST: In India, Bayer will be providing over 200,000 units of face masks (3 ply), 2000 units of N-95 masks, Personal Protective Equipment (PPE) kits and other medical supplies to various healthcare professionals in the country to help them in their fight against the virus. Furthermore, we are also helping other companies to engage in relief activities by helping them procure the PPE kits through our vendor network and helping to transport the same to various hospitals.

March 30

Zoom image

08:00 p.m. CEST: With the significant burden COVID-19 is having on the healthcare systems and increased need for self-care solutions, Bayer announced today a donation of one million products to support the health of underserved communities. The products, including over-the-counter medications and multivitamins, will be delivered directly to Americans who can’t easily access them today by way of partnerships with Direct Relief and, in subsequent weeks, Feeding America.

07:00 p.m. CEST: “Bayer is there to support you.” This is the message to the agriculture community from Liam Condon, President, Crop Science. Condon’s video message recognizes the extraordinary work taking place in the health care industry and acknowledges the work in the agriculture space is equally important to ensure the coronavirus health crisis does not also become a hunger crisis. He pledges that our employees remain committed to putting our customers first and providing business continuity as best they can during this unprecedented time.

11:00 a.m. CEST: Bayer is making more than 40 virus diagnostic devices from its research facilities available at various locations in Germany, which will increase the nationwide COVID-19 analysis capacity by several thousand tests per day. We are also providing specially trained staff. NRW’s Minister of Health Karl-Josef Laumann expressly thanked the company for this contribution.

March 27

Zoom image

05:15 p.m. CET: The Bayer Annual Stockholder’s Meeting this year will not look like this. We plan to hold our Annual Stockholders’ Meeting as an online-only event for the first time in Bayer’s history as a result of the continuing spread of the coronavirus. The health and wellbeing of participants in the stockholders’ meeting is a top priority for Bayer.

04:00 p.m. CET: Production in a pandemic: How to produce medicines in a state of emergency? Our recent report about our team in Garbagnate/Italy is currently demonstrating that in an impressive way.

08:00 a.m. CET: While testing for COVID-19 ramps up, there’s another kind of testing that will prove equally important to combating the pandemic: one that can detect whether someone has already been infected and therefore is protected. Leapsmag has published a very interesting interview about this. Leapsmag was created by Leaps by Bayer, a new innovation initiative whose mission is to “aim for fundamental breakthroughs in the life sciences – ‘leaps’ that have the potential to change our world for the better.”

March 26

09:00 a.m. CET: Researchers at Bayer have launched an internal platform under the tagline “Science4Help”. All of our researchers are encouraged to use this platform to share and discuss ideas for combating the coronavirus, as a way of enabling us to leverage our in-house creative potential.

08:00 a.m. CET: How long will we suffer from Corona? SynBioBeta, a partner of Leaps by Bayer, answers this in an easy to understand infographic.

March 25

Zoom image

02:20 p.m. CET: The production employees work together to maintain production. Colleagues like here in Berlin enjoy coming to work and are proud of what they are currently doing - and rightly so! “The colleagues accepted and supported all the changes and the increased burden of the past weeks without complaint. You work with a motivation and productivity that is second to none. Everyone pulls together - for our common goal: to ensure the supply of medicines to patients, especially in these times. I am incredibly proud of our entire team at SCB”, says Norbert Nickel, 2nd Plant Manager Packaging Solids.

Brett Begemann, Chief Operating Officer, Crop Science

09:00 a.m. CET: “We are all in this together!” This is the headline of a letter to our customers from Brett Begemann, Chief Operating Officer, Crop Science. He writes: “You, the farmers – big or small in all parts of the globe, play a critical role in providing the world with a stable supply of food, feed, fiber and sometimes fuel. You are essential in keeping a health crisis from turning into so much more. Let me assure you that we are absolutely committed to providing the valuable seeds, crop protection and services that you need to help ensure food and feed are produced.”

08:00 a.m. CET: Employees of the Pharmaceuticals Division with a medical background can register to volunteer in the fight against the coronavirus. Bayer is supporting the local health care system by giving these employees paid leave for a period of up to 4 weeks so that they can volunteer during this time. With numerous physicians and paramedical practitioners among its staff, Bayer is well positioned to help meet the urgent demand for specialist personnel.

March 24

Zoom image

10:30 a.m. CET: In Berlin and Wuppertal we are providing local hospitals with ventilators from our pharmacology labs. From our site in Dormagen, we are also providing the City of Leverkusen with urgently needed masks to keep health care workers safe.

March 22

03:00 p.m. CET: The WHO is launching a global study to test whether existing drug products can be used to treat corona. One of these products is Bayer’s active ingredient chloroquine (trade name: Resochin).

March 20

09:00 a.m. CET: We are assessing our capabilities for producing disinfectants, which are currently in such short supply, as a matter of urgency. In Germany we are drawing on the expertise of our plants in Wuppertal and Bergkamen. Our facility in Cimanggis, Indonesia, has decided to produce hand sanitizers locally to protect employees and their families. As of March 19th, they have already produced approximately 250 liters of disinfectants.

March 19

07:00 p.m. CET: Just recently it was announced that US health authorities will be supported in the fight against SARS-CoV-2 with the malaria drug chloroquine.

March 18

Zoom image

01:00 p.m. CET: We are supporting hospitals in Lombardy, Italy, with a donation of one million euros. The money is being added to an aid fund that the regional authorities in Lombardy have set up to help procure urgently needed equipment for intensive care units in hospitals with the greatest needs.

March 17

10:00 a.m. CET: Bayer CEO Werner Baumann addresses all of the company’s stakeholders in a message. He pledges that Bayer will remain a dependable partner for its customers throughout the current crisis and that it will support health authorities all over the world in the fight against the epidemic.

March 13

11:30 a.m. CET: Bayer’s Board of Management sends a letter to employees around the world and outlines the top priorities during the crisis: protecting their health and keeping production running so that we can continue to supply our products to people who need them. All employees able to work from home are asked to do so.

Our contribution to fighting corona

The COVID-19 pandemic wages on and so does our commitment to support the fight against it.

As a company active in the areas of health and nutrition, we can provide substantial help in overcoming the crisis with our products and our expertise. Our employees are working round the clock to do just that.


The safety and well-being of our employees is a top priority. Wherever possible, employees in affected areas are encouraged to work from home. Employees who can only carry out their work at the site follow extended safety and distance regulations. Our most recent initiative will provide four cloth masks to each of our more than 100,000 employees across the globe.

Our employees continue to inspire with their volunteer activities to support the efforts to fight against the COVID-19 pandemic. Their passion, dedication and creativity are making an impact at work, in their communities and beyond.

We continue to look after our employees’ health and safety

  • We have taken the necessary measures to limit the spread of the coronavirus within our sites.
  • We follow the guidance and orders provided by Governments and Health authorities and update our employees on the latest developments.
  • All employees can continue to work from home until further notice if their duties allow. With schools and day care centers closed, this gives them the flexibility to temporarily look after their children themselves or make alternative arrangements.
  • Bayer will provide four cloth masks to each of our more than 100,000 employees across the globe.

Our employees go the extra mile to fight COVID-19 in their communities and beyond – here are a few examples

  • Bayer is encouraging employees, especially those with medical backgrounds, to take paid leave and support local healthcare needs. For example, more than 140 employees volunteered to staff the new testing laboratory at our Berlin campus. Bayer is giving them a leave of absence from their regular jobs to do so.
  • Employees across R&D, Communications, Legal, Commercial, Quality and others volunteered to augment staffing at our Radiology production site in Indianola, PA, to ensure continued support of patient imaging procedures during the pandemic. Volunteers are loading syringes and tube sets on the packaging machines, working on the manual assembly lines, and stuffing pouches for packaging.
  • The employees of the Technical Discovery Center (TDC) in Chesterfield, MO stepped in to produce more than 400,000 face shields in cooperation with Stratasys, a leading manufacturer of 3D printers, to help doctors, nurses, and first aiders protect themselves from infection because, unlike respiratory masks, these shields also protect the top half of the person’s face.
  • Colleagues at our facility in Lerma, Mexica converted a 3D printer to produce transparent face shields to donate to hospitals, health centers and other health facilities in the country.
  • Employees at our site in Dormagen, Germany have produced more than 50,000 liters of urgently needed disinfectants and distributed them free of charge to the surrounding communities.
  • The employees at our site in Proquina, Orizaba, Mexico, also produce disinfectants for surrounding hospitals. An initial order of 11,000 liters of disinfectant will be produced there and distributed to the general public free of charge.

Our Customers

We continue to implement the necessary measures to ensure business continuity in our operations during these challenging times. Safely delivering a sustainable supply of products and services to hospitals, doctors, patients, consumers and farmers is a top priority.

Our commitment to business continuity

  • We’re working at full steam so that we can safely provide patients, consumers and farmers with the products they urgently need at this time.
  • Our organization and in particular our production facilities in the countries most affected by the corona outbreak are working largely according to plan.
  • We continue to ensure safe operations at every site. For essential personnel that are working at our sites, we have introduced and strengthened measures to increase hygienic levels and social distancing in order to protect our employees and safeguard production. When and where possible, we are beginning to return to standard operations in a gradual and differentiated manner that enables us to quickly retighten restrictions if needed.
  • We continue to monitor the situation, and the emergency response plans we have prepared for all sites will be implemented as necessary to ensure our facilities continue to operate safely and effectively for as long as possible.
  • We are putting a special emphasis on logistics. With more and more countries with closed borders, causing long traffic jams and limiting air and ocean freight capacity, we are working closely with our logistics partners and industry peers to secure supply for our customers across the globe.

We put measures in place to protect our product supply, thereby ensuring that patients and consumers will continue to receive any essential medication they need

  • Our general inventory policy includes buffers for our sourced material. We continuously and closely monitor the situation worldwide.
  • We set up a global crisis team as well as local teams to secure production of Active Pharmaceutical Ingredients, Pharmaceuticals and Medical Devices and our sourcing colleagues are in regular contact with suppliers and freight forwarders.
  • We remain well-prepared in response to the increased consumer demand for our over-the-counter products, especially in the cough & cold, allergy and nutritionals categories, but urge consumers not to buy beyond their needs as hoarding may impact availability at the shelf.

Our focus is to ensure agriculture operations continue uninterrupted, so this health crisis does not become a hunger crisis

  • We have measures in place to maintain the timely sourcing and transport of our essential seeds, chemistries and services to help ensure farmers globally can produce the high-quality harvests we all rely on.
  • We remain able to successfully deliver seeds and crop protection to farmers globally and are committed to keeping our partners and customers informed of product availability and any changes that may come in the days or weeks to follow.
  • We continue to work to ensure agriculture operations are designated as essential so that global markets stay open to enable trade to continue to flow and ensure agriculture can continue to operate effectively.


In these trying times, health and nutrition — two of our most basic needs — take on even more importance. Fueled by our vision “Health for All, Hunger for None”, Bayer is collaborating with government agencies, health authorities and other organizations around the world in the fight against COVID-19 with a variety of efforts, including financial contributions, the donation of medicines, medical, diagnostic and protective equipment, and the leveraging of dedicated research space at select Research & Development sites to increase testing capacity.

As of May 6, 2020, Bayer has donated supplies, products and monetary support to more than 60 countries totaling over 12 million euros. Here are a few examples.

We’re providing financial assistance in severely affected areas to provide assistance quickly and efficiently

  • EUR 1 million donation each to various government and health care authorities in the European countries worst affected by the pandemic – Italy, Spain and France.
  • EUR 1 million donation to three different initiatives in Brazil —the Arrecada??o Solidária, a Federal Government's project, the United Nations Children's Fund (UNICEF) — for the purchase of safety items and hospital supplies.
  • EUR 568.000 to the Red Cross Society in China deployed where most needed.

We’re donating medicines as well as over-the-counter medications

  • Resochin? (chloroquine): donated several million tablets to government and health authorities across the globe including Germany, Italy, and the US.
  • In the United States, patients who take prescription Bayer medicines and who have lost their insurance coverage and find themselves in financial need as a result of the corona crisis will receive immediate free access to these medicines from us.
  • 1.5 million units of every day healthcare products donated globally to date including 1 million over-the-counter medications and multivitamins to Americans who can’t easily access them today as well as donations of Bepanthen? to over 100,000 frontline healthcare professionals in 27 countries to ease their skin from the effects of wearing masks and gloves for extended periods of time.

We’re donating medical and protective equipment

  • Over 600,000 respiratory masks and other personal protection equipment (PPE), such as protective goggles and gloves, have already been donated to various countries, such as China, India, Poland, and Argentina.
  • In Germany, 200,000 masks were donated from its own inventory to the Red Cross.
  • At the technical development center (TDC) at our research and development headquarters in Chesterfield, Missouri, 400,000 face shields have been produced in cooperation with Stratasys, a leading manufacturer of 3D printers, to help doctors, nurses, and first aiders protect themselves from infection because, unlike respiratory masks, these shields also protect the top half of the person’s face.
  • A converted 3D printer at our facility in Lerma, Mexico, is producing transparent face shields to donate to hospitals, health centers and other health facilities in the country.
  • At our site in Dormagen, Germany, we have produced more than 50,000 liters of urgently needed disinfectants and distributed them free of charge to the surrounding communities.
  • Our site in Proquina, Orizaba, Mexico, also produces disinfectants for the surrounding hospitals. An initial order of 11,000 liters of disinfectant will be produced there and distributed to the general public free of charge.

We’re offering diagnostics devices and space to accelerate COVID-19 testing capacity

  • We made virus diagnostics devices available from our research operations from various German sites, enabling Germany’s COVID-19 analysis capacity to be increased by several thousand tests daily.
  • We are also lending PCR devices to hospitals in France and Spain.
  • In North Rhine-Westphalia, Germany, the company is providing equipment to certified external testing laboratories, as well as supplying three certified clinical diagnostic laboratories with company apparatus from the Leverkusen, Monheim, Wuppertal and Cologne sites. In addition, we established a two-story testing laboratory at our Berlin campus, and more than 140 employees have volunteered to staff the new testing laboratory. Bayer is giving them a leave of absence from their regular jobs for this purpose.

We joined forces with other organizations to maximize resources in the search for new treatments

  • We are supporting the COVID-19 Therapeutics Accelerator Initiative of the Bill & Melinda Gates Foundation by opening up our vast compound library to find and develop effective novel compounds against COVID-19.
  • We committed EUR 500,000 to the Innovative Medicines Initiative (IMI) for the screening of a molecular target against the Bayer substance library.
  • Bayer is partnering with the Population Health Research Institute (PHRI) in Canada to launch a major clinical research program aimed at identifying potential treatments against COVID-19. The two studies will test the safety and efficacy of several different combination therapies including Resochin? and Betaferon?.

We’re providing resources to help with the added pressures of the Shelter-in-Place restrictions

Science at Home with Bayer is a bi-weekly series that features fun STEM educational activities parents can use to keep their kids learning while staying at home. Your child may not be able to attend school right now, but their curiosity and love for science can continue at home!